MENU
+Compare
ANAB
Stock ticker: NASDAQ
AS OF
Apr 4, 04:59 PM (EDT)
Price
$18.51
Change
-$0.78 (-4.04%)
Capitalization
590.64M

ANAB AnaptysBio Forecast, Technical & Fundamental Analysis

AnaptysBio Inc is a clinical-stage biotechnology company... Show more

Industry: #Biotechnology
ANAB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for ANAB with price predictions
Apr 01, 2025

ANAB in -2.90% downward trend, sliding for three consecutive days on April 01, 2025

Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where ANAB declined for three days, in of 323 cases, the price declined further within the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

ANAB broke above its upper Bollinger Band on March 24, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 62 cases where ANAB's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on March 20, 2025. You may want to consider a long position or call options on ANAB as a result. In of 101 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for ANAB just turned positive on March 20, 2025. Looking at past instances where ANAB's MACD turned positive, the stock continued to rise in of 51 cases over the following month. The odds of a continued upward trend are .

ANAB moved above its 50-day moving average on March 20, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ANAB advanced for three days, in of 284 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 194 cases where ANAB Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ANAB’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to slightly better than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (8.333) is normal, around the industry mean (13.338). P/E Ratio (0.000) is within average values for comparable stocks, (63.865). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.864). Dividend Yield (0.000) settles around the average of (0.025) among similar stocks. P/S Ratio (5.988) is also within normal values, averaging (249.417).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ANAB’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
ANAB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

ANAB is expected to report earnings to rise 80.56% to -129 cents per share on May 08

AnaptysBio ANAB Stock Earnings Reports
Q1'25
Est.
$-1.30
Q4'24
Beat
by $0.90
Q3'24
Beat
by $0.56
Q2'24
Missed
by $0.67
Q1'24
Missed
by $0.05
The last earnings report on February 27 showed earnings per share of -72 cents, beating the estimate of -162 cents. With 375.99K shares outstanding, the current market capitalization sits at 590.64M.
A.I. Advisor
published General Information

General Information

a provider of therapeutic antibodies for inflammation and immuno-oncology

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
10770 Wateridge Circle
Phone
+1 858 362-6295
Employees
117
Web
https://www.anaptysbio.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
BTC.X83102.830000617.109400
+0.75%
Bitcoin cryptocurrency
SPY536.70-27.82
-4.93%
SPDR® S&P 500® ETF Trust
TSLA267.28-15.48
-5.47%
Tesla
GME21.10-1.59
-7.01%
GameStop Corp
AAPL203.19-20.70
-9.25%
Apple

ANAB and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ANAB has been loosely correlated with CLRB. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if ANAB jumps, then CLRB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANAB
1D Price
Change %
ANAB100%
+1.69%
CLRB - ANAB
45%
Loosely correlated
-2.95%
ADCT - ANAB
40%
Loosely correlated
-7.52%
HRMY - ANAB
38%
Loosely correlated
-4.80%
SPRY - ANAB
34%
Loosely correlated
+2.68%
IBRX - ANAB
34%
Loosely correlated
-2.62%
More